| Literature DB >> 27741506 |
Dongzhu Lei1, Shaoyuan Li2, Santasree Banerjee2, Haoqing Zhang1, Caiyun Li1, Shuai Hou1, Danjing Chen1, Haiying Yan1, Hanmei Li3, Huan Huan Peng2, Saijun Liu2, Xinxin Zhang2,4, Zhiyu Peng2, Jian Wang2, Huanming Yang2,5, Hui Huang2, Jing Wu2.
Abstract
Phelan-McDermid syndrome is a neurodevelopmental disorder caused by the terminal deletion of chromosome 22 (22q13) followed by the loss of function of the SHANK3 gene. Various terminal deletions of chromosome 22q13 are associated with Phelan-McDermid with a spectrum of phenotypic severity. Here, we have done a clinical molecular study of a Chinese proband with Phelan-McDermid syndrome. Both the proband and her younger brother are associated with this syndrome while their parents are phenotypically normal. We used a karyotype in order to detect the genotype of the proband and her younger brother. We have also used whole genome low-coverage paired-end next generation sequencing to determine whether the parent is the carrier of translocation with terminal 22q13 deletions. We found that both proband and her younger brother are comprises of a novel deletion of 22q13.31q13.33, harboring genes were associated with several clinical phenotype such as severity of speech delay, neonatal hypotonia, delayed in age of walking, male genital anomalies, dysplastic toenails, large and fleshy hands, macrocephaly, short stature, facial asymmetry, and atypical reflexes. Probands and her younger brother inherited this translocation from their mother whereas their father is genotypically normal. In conclusion, our present study expands the deletion spectrum and report a novel deletion associated with Phelan-McDermid syndrome.Entities:
Keywords: 22q13 deletion syndrome; Phelan–McDermid syndrome; SHANK3; novel deletion; translocation
Mesh:
Year: 2016 PMID: 27741506 PMCID: PMC5348323 DOI: 10.18632/oncotarget.12552
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Figure 1A. Pedigree of Chinese Family showing the proband and her little brother with intellectual disability. The filled symbol indicates the affected individuals, open symbol belongs to unaffected individuals, circle with a dot represents a asymptomatic carrier, square represents male and circles represents female. Arrow indicates the proband. B., C. Chinese proband associated with intellectual disability and absence of speech, low level of understanding, wryneck, strabismus, and duck walking. D. Chinese proband's large and fleshy palms print pass through hand.
Figure 2Ultrasonography showed
A. double kidney effusion and B. normal heart. CT scan showed C. right side schizencephaly and D. callosal agenesis.
Figure 3A. Chromosomes karyotype result, 46,XX of the proband (II-1). B. Electronic karyotype diagram of the Proband (II-1) Sequencing. “DUP” indicates “dupplication”; “DEL” indicates “deletion”; “BCA” represents balanced translocation; “INV” represents inversion; “INS” for insertion.
Figure 4A. Chromosomes karyotype result, 46,XY of the Proband's little brother (II-2). B. Electronic karyotype diagram of the Proband's little brother (II-2) Sequencing. “DUP” indicates “duplication”; “DEL” indicates “deletion”; “BCA” represents balanced translocation; “INV” represents inversion; “INS” for insertion.
Figure 5A.-B. Electronic karyotype diagram of the Proband's mother (I-2) Sequencing. “DUP” indicates “duplication”; “DEL” indicates “deletion”; “BCA” represents balanced translocation; “INV” represents inversion; “INS” for insertion.
Genotype of Proband and all the family members
| Affected Family Members | Sequencing result (GRch37/hg19) | Fragment size | Overlapping known syndrome | OMIM No. | Pathogenic genes included in OMIM |
|---|---|---|---|---|---|
| Proband (II-1) | 46, XX, dup (9) (q 34.3), del (22) (q13.31 q13.33) | dup9:139372567-49358188, 1.58Mb; del 22.44882702-51146914, 6.26Mb | Partial overlap of 22q13 deletion syndrome | 606232 | SHANK3, NOTCH1, AGPAT2, MAN1B1, GRIN1, TPRN, SLC34A3, NELF, EHMT1 |
| Proband's younger brother (II-2) | 46, XY, del (22q13.31q13.33), dup(9q34.3) | dup9:139, 367, 413-141, 077, 092, 1.71Mb; del 22:44, 882, 702-51, 146, 914, 6.26Mb | Partial overlap of 22q13 deletion syndrome | 606232; 251270; 250100 | SHANK3; TUBGCP6; ARSA; ATXN10; ALG12; MLC1 |
| Proband's mother (I-2) | 46, XX, t(9;22) (q34.3; q13.31) | t(9;22) ((139, 372, 903-139, 373, 283); (44, 909, 509-44, 909, 776)) | - | - | - |
| Proband's father (I-1) | 46, XY | - | - | - | - |
Sequencing depth and the accuracy for calling a variant in low coverage shallow sequencing
| Sample | Read_Length | Reads | Map_Rate | Sequencing Depth | Sequencing type |
|---|---|---|---|---|---|
| Proband (II-1) | 49 | 24636014(24.64M) | 96.18% | 0.41 | SE 50 Sequence |
| Proband's younger Brother (II-2) | 49 | 27633974(27.63M) | 96.01% | 0.46 | SE 50 Sequence |
| Proband's Mother (I-2) | 50 | 60028505(60.03M) | 78.84% | 1 | PE 50 Sequence |
| Proband's Father (I-1) | 50 | 57645333(57.65M) | 78.71% | 0.96 | PE 50 Sequence |